Molecular epidemiology of Staphylococcus aureus colonization in a burn center

Burns

Volumn 30, Issue 1, 2004, Pages 27-33

  Kooistra Smid, Mirjam ^a   Van Dijk, Sjoukje ^b   Beerthuizen, Gerard ^b   Vogels, Willem ^a   Van Zwet, Ton ^a   Van Belkum, Alex ^c   Verbrugh, Henri ^c  

^a Public Health Service of Groningen   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Burn center; Burn wound colonization; Staphylococcus aureus

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CARRIER; BURN; BURN INFECTION; CONTROLLED STUDY; CROSS INFECTION; GENETICS; GENOTYPE; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; NONHUMAN; NOSE; PATIENT CARE; STAPHYLOCOCCUS AUREUS; THROAT;

EID: 0348229000     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2003.09.014     Document Type: Article

References (38)

1. Adeniran A., Shakespeare P., Patrick S., Fletcher A.J., Rossi L.A. Influence of a changed care environment on bacterial colonization of burn wounds. Burns. 21:1995;521-525.
2. Bannerman T.L., Hancock G.A., Tenover F.C., Miller M. Pulsed field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J. Clin. Microbiol. 33:1995;551-555.
3. vandenBergh M.F.Q., Yzerman E.P.F., van Belkum A., Boelens H.A.M., Sijmons M., Verbrugh H.A. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J. Clin. Microbiol. 37:1999;3133-3140.
4. Bonten M.J., Hayden M.K., Nathan C., van Voorhuis J., Matushek M., Slaughter S., Rice T., Weinstein R.A. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet. 348:1996;1615-1619.
5. Boyce J.M., Mermel L.A., Zervos M.J., Rice L.B., Potter-Bynoe G., Giorgio C., Medeiros A.A. Controlling vancomycin-resistant enterococci. Infect. Control Hosp. Epidemiol. 16:1995;634-637.
6. Cookson B., Peters B., Webster M., Philips I., Rahman M., Noble W. Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 27:1989;1471-1475.
7. Krivan H.C., Roberts D.D., Ginsburg V. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc. Natl. Acad. Sci. U.S.A. 85:1988;6157-6161.
8. Manson W.L., Pernot P.C.J., Fidler V., Sauer E.W., Klasen H.J. Colonization burns and the duration of hospital stay of severely burned patients. J. Hosp. Infect. 22:1992;55-63.
9. Noskin G.A., Stosor V., Cooper I., Peterson L.R. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect. Control Hosp. Epidemiol. 16:1995;577-581.
10. Patti J.M., Allen B.L., McGavin M.J., Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48:1994;585-617.
11. Peacock S.J., de Silva I., Lowy F.D. What determines nasal carriage of Staphylococcus aureus? Trends Microbiol. 9(12):2001;605-610.
12. Pittet D., Hugonnet S., Harbarth S., Mourouga P., Sauvan V., Touvenean S., Perneger T.V. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 356:2000;1307-1312.
13. Pruitt B.A. Jr., McManus A.T., Kim S.H., Goodwin C.W. Burn wound infections: current status. World J. Surg. 22(2):1998;135-145. [Review].
14. Ransjö U. Attempts to control clothes-borne infection in a burn unit, clothing routines in clinical use and the epidemiology of cross-colonization. J. Hyg. (Camb.). 82:1979;369-384.
15. Reardon C.M., La H., Brown T.P., Stephenson A.J., Freedlander E. Methicillin-resistant Staphylococcus aureus in burns patients: why all the fuss? Burns. 24:1998;393-397.
16. Shiomori T., Miyamoto H., Makishima K., Yoshida M., Fujiyoshi T., Udaka T., Inaba T., Hiraki N. Evaluation of bedmaking-related airborne and surface methicillin-resistant Staphylococcus aureus contamination. J. Hosp. Infect. 50:2002;30-35.
17. Song W., Lee K.M., Kang H.J., Shin D.H., Kim D.K. Microbiological aspects of predominant bacteria isolated from the burn patients in Korea. Burns. 27(2):2001;136-139.
18. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:1995;2233-2239.
19. Taylor G.D., Kibsey P., Kirkland T., Burroughs E., Tredget E. Predominance of staphylococcal organisms in infections occurring in a burns intensive care unit. Burns. 18(4):1992;332-335.
20. Vindenes H., Bjerknes R. Microbial colonization of large wounds. Burns. 21:1995;575-579.
21. Vránková J., Bendová E., Königová R., Broñ L. Bacteriological monitoring in the Prague Burns Center. Acta Chir. Plast. 40(4):1998;105-108.
22. Solberg C.O. Spread of Staphylococus aureus in hospitals: causes and prevention. Scand. J. Infect. Dis. 32(6):2000;587-595.
23. Corbella X., Domínguez M.A., Pujol M., Ayats J., Sendra M., Pallares R.et al. Staphylococcal aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur. J. Clin. Microbiol. Infect. Dis. 16:1997;351-357.
24. van Rijn R.R., Kuijper E.C., Kreis R.W. Seven-year experience with a 'quarantine and isolation unit' for patients with burns. A retrospective analysis. Burns. 23(4):1997;345-348.
25. Thompson J.T., Meredith J.W., Molnar J.A. The effect of burn nursing units on burn wound infections. J. Burn Care Rehabil. 23(4):2002;281-286.
26. British Society of Antimicrobial Agents and Hospital Infection Society. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998;39: 253-90.
27. Bertino J.S. Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus. Am. J. Health Syst. Pharm. 54:1997;2185-2191.
28. Kluytmans J.A., Mouton J.W., van den Bergh M.F., Manders M.J., Maat A.P., Wagenvoort J.H.et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 17(12):1996;780-785.
29. Cimochowski G.E., Harostock M.D., Brown R., Bernardi M., Alonzo N., Coyle K.et al. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann. Thorac. Surg. 71(5):2001;1572-1578. [discussion 1578-9].
30. Martin J.N., Perdreau-Remington F., Kartalija M., Pasi O.G., Webb M., Gerberding J.L.et al. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. J. Infect. Dis. 180(3):1999;896-899.
31. Kluytmans J.A., Manders M.J., van Bommel E., Verbrugh H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect. Control Hosp. Epidemiol. 17(12):1996;793-797.
32. Mackie D.P., van Hertum W.A., Schumburg T.H., Kuijper E.C., Knape P., Massaro F. Reduction in Staphylococcus aureus wound colonization using nasal mupirocin and selective decontamination of the digestive tract in extensive burns. Burns. 20(Suppl 1):1994;S14-S17. [discussion S17-8].
33. Doebelling BN, Reagan DR, Pfaller MA, Houston AK, Hollis RJ, Wenzel RP. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 1994;11154 (13):1505-8.
34. Dupeyron C., Campillo B., Bordes M., Faubert E., Richardet J.P., Mangeney N. A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit. J. Hosp. Infect. 52(4):2002;281-287.
35. Casewell M.W., Hill R.L. Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid')-a controlled trial. J. Antimicrob. Chemother. 17(3):1986;365-372.
36. Fernandez C., Gaspar C., Torrellas A., Vindel A., Saez-Nieto J.A., Cruzet F. A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel. J. Antimicrob. Chemother. 35(3):1995;399-408.
37. Harbarth S., Dharan S., Liassine N., Herrault P., Auckenthaler R., Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 43(6):1999;1412-1416.
38. Cookson B.D. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J. Antimicrob. Chemother. 41(1):1998;11-18.